Displaying items by tag: mental health and psychiatry
UAB researchers are looking for adults (ages 25-65) who are suffering from demoralization - feelings of hopelessness or meaninglessness - to participate in a research study evaluating a novel medication.
To see if you qualify call 205-379-7527.
To see if you qualify call 205-379-7527.
Published in
Clinical Trials
CURB-2 is an abbreviation we use to refer to this study because there was a similar study completed and published in 2016 called CURB, which stands for Cocaine Use Reduction with Buprenorphine. The results from that study showed that using injectable naltrexone and sublingual buprenorphine was beneficial to participants on high doses of the medication. This study will give injectable naltrexone and injectable buprenorphine to make sure medication doses are consistent to confirm potential benefits.
There are no approved treatments specifically for cocaine use disorder. We are looking for adults (18-65 years of age) who are using cocaine and who are interested in reducing or stopping their use. The purpose of our study is to test a combination of two medications for 2 months as a possible treatment for cocaine use disorder.
This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine. Study medication and assessments will be provided to participants at no cost. Participants will receive compensation for their time and efforts.
Study information will be kept strictly confidential. Your privacy is important to us.
Call us for more information at 205-996-0211 or email us at curb2study@uabmc.edu
There are no approved treatments specifically for cocaine use disorder. We are looking for adults (18-65 years of age) who are using cocaine and who are interested in reducing or stopping their use. The purpose of our study is to test a combination of two medications for 2 months as a possible treatment for cocaine use disorder.
This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine. Study medication and assessments will be provided to participants at no cost. Participants will receive compensation for their time and efforts.
Study information will be kept strictly confidential. Your privacy is important to us.
Call us for more information at 205-996-0211 or email us at curb2study@uabmc.edu
Published in
Clinical Trials
Do you identify as an individual living with cancer and part of the LGBTQIA+ community or a care partner of someone in this community? A research lab at the University of Alabama at Birmingham is looking to learn about the day-to-day experiences of LGBTQIA+ cancer survivors and their care partners. We are interested in how individuals manage difficult situations related to their respective roles in their relationships. Individuals living with cancer often encounter stressful situations that can impact their mood and any additional stressors from living as a sexual or gender minority with a lack of resources adds an increased risk of experiencing stressful situations. The goal of this work is to develop resources that better support the well-being of LGBTQIA+ individuals living with cancer and their care partners. This study will take place FULLY online with completion of daily surveys. All participants will be compensated. To learn more about our study contact us at starlab@uab.edu
Published in
Clinical Trials
The University of Alabama at Birmingham (UAB) is inviting Hispanic or Latino/a family caregivers to complete short surveys for our study. Your answers will help us understand your daily experiences and develop services to better support caregivers in the community. You will be paid for your time. Your answers will remain anonymous. To learn more contact us at starlab@uab.edu or call Lorelí Alvarez at 205-996-0339.
To be contacted by the research team register here: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU
¿Cuidas de un familiar con problemas de memoria o demencia/enfermedad de Alzheimer?
La Universidad de Alabama en Birmingham (UAB) está invitando a cuidadores familiares hispanos y latinos para que completen breves encuestas para nuestro proyecto. Tus respuestas ayudarán a comprender mejor las experiencias del día a día y a desarrollar servicios para apoyar mejor a los cuidadores familiares de la comunidad. Les compensaremos por su participación. Sus respuestas permanecerán anónimas. Para saber más escribe a starlab@uab.edu o llama por teléfono al 205-996-0339 y pregunta por Lorelí Alvarez.
Para ser contactado por el equipo de investigación haga click aquí: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU
To be contacted by the research team register here: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU
¿Cuidas de un familiar con problemas de memoria o demencia/enfermedad de Alzheimer?
La Universidad de Alabama en Birmingham (UAB) está invitando a cuidadores familiares hispanos y latinos para que completen breves encuestas para nuestro proyecto. Tus respuestas ayudarán a comprender mejor las experiencias del día a día y a desarrollar servicios para apoyar mejor a los cuidadores familiares de la comunidad. Les compensaremos por su participación. Sus respuestas permanecerán anónimas. Para saber más escribe a starlab@uab.edu o llama por teléfono al 205-996-0339 y pregunta por Lorelí Alvarez.
Para ser contactado por el equipo de investigación haga click aquí: https://uab.co1.qualtrics.com/jfe/form/SV_d3TmeAlFEPBRmNU
Published in
Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in
Clinical Trials
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
The STARS Lab lead by Dr. Caroline G. Richter is currently recruiting for the study: Socio-emotional competencies in children and adolescents with learning differences
This study seeks to examine socio-emotional constructs, such as motivation, resilience, and stigma using an assessment survey. The project’s final goal is to provide educators and parents with targeted socio-emotional intervention techniques for a more holistic perspective on student learning.
All English-speaking children from 11 to 14 years of age are eligible. Students with Specific Learning Disabilities are encouraged to participate.
Click here to learn more: https://drive.google.com/file/d/1JCw1f7PfRTRHJhdlV39ZHH_g3nThBwBq/view?usp=sharing
This study seeks to examine socio-emotional constructs, such as motivation, resilience, and stigma using an assessment survey. The project’s final goal is to provide educators and parents with targeted socio-emotional intervention techniques for a more holistic perspective on student learning.
All English-speaking children from 11 to 14 years of age are eligible. Students with Specific Learning Disabilities are encouraged to participate.
Click here to learn more: https://drive.google.com/file/d/1JCw1f7PfRTRHJhdlV39ZHH_g3nThBwBq/view?usp=sharing
Published in
Clinical Trials
We are conducting a research project to examine effects of a coach-guided videoconferencing acceptance and commitment therapy (ACT) program on improving psychological health (e.g., depressive symptoms) in persons with a spinal cord injury sustained within 5 years. You may qualify for the study if you are adults (age 18 or over) who had a traumatic or non-traumatic spinal cord injury within 5 years and have a web-enabled device (a computer/laptop, a smartphone, or a tablet PC) with the internet access at home. This study will involve completion of questionnaires three times and 8 weekly videoconferencing sessions by the ACT coach if you are assigned to the ACT group. Participants will be compensation at study completion (up to $215 as the ACT group). For questions and more information, contact Jessica Hawkins at jshawkins@uabmc.edu or 205-975-2882.
Published in
Clinical Trials
Are you between the ages of 11 and 19?
Are you felling sad, down, or hopeless?
Are you feeling guilty, tense, or irritable?
If so, you may be eligible to participate in a study.
Compensation provided.
For more information, please call Brennan wink at 205-975-4208 or send an
email to Brennanwink@uabmc.edu
Are you felling sad, down, or hopeless?
Are you feeling guilty, tense, or irritable?
If so, you may be eligible to participate in a study.
Compensation provided.
For more information, please call Brennan wink at 205-975-4208 or send an
email to Brennanwink@uabmc.edu
Published in
Clinical Trials
We are conducting a research project to evaluate if coach-guided videoconferencing acceptance and commitment therapy (ACT) is effective for improving psychological health in family caregivers of people with dementia. You may qualify for the study if you are adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community (i.e., your relative is not living in a nursing home) and have a web-enabled device (a computer/laptop, a smartphone, or a tablet PC) with the internet access at home. This study will involve completion of questionnaires three times and 10 weekly videoconferencing sessions by the ACT coach if you are assigned to the ACT group. Participants will be compensation at study completion (up to $150 as the ACT group). For questions and more information, contact Jessica Hawkins at jshawkins@uabmc.edu or 205-975-2882.
Published in
Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in
Clinical Trials
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
You may be able to participate in this study if you: are 18 years of age or older, have been diagnosed with major depressive disorder, MDD, have not adequately responded to at least 1 different antidepressant treatment, and are currently on an antidepressant treatment. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.
Published in
Clinical Trials
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Published in
Clinical Trials
Feel like you're missing out? If you are being treated for major depressive disorder (MDD) but still feel a lack or loss of interest in usually pleasurable activities, the TERPSIS Study, a clinical research study on an investigational medication for MDD, be of interest to you. The TERPSIS Study is researching a potential MDD therapy to improve symptoms of depression, and you may be eligible to participate. This study is now enrolling adults diagnosed with MDD Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no costs. Participants in the TERPSIS Study must: -Be 18 to 65 years of age -Have a clinical diagnosis of MDD -Are currently taking or have recently taken antidepressant medication(s) -Still feel a lack of interest in usually pleasurable activities -Fulfill other eligibility criteria For more information, please email kristinepike@uabmc.edu or call 205-975-8542.
Published in
Clinical Trials
A clinical research study is now enrolling eligible adults. The purpose of this study is to evaluate the effectiveness, safety, and tolerability of an investigational medication when it is used alone in people with TRD. You may be eligible to participate if you: • Are 18 years of age or older • Have been diagnosed with TRD • Have not adequately responded to at least 2 different antidepressant treatments If you are interested, additional eligibility criteria will be assessed by the study doctor or staff. The commitment for the study is about 24 weeks. Qualified patients may receive investigational study medication and some study-required medical care at no cost. For more information about this study, you may visit www.clinicaltrials.gov and search “54135419TRD4005” or contact Kristine at 205-975-8542 or kristinepike@uabmc.edu.
Published in
Clinical Trials
We are enrolling opioid users without a history of psychosis, endocrine diseases, inflammatory diseases, or autoimmune diseases. If you meet these criteria you may be eligible to participate in a research study. Compensation provided up to $20. For more information, please call the UAB Office of Psychiatric Research at 205-934-8336.
Published in
Clinical Trials
We are looking for adults between 21-55 years old and diagnosed with Attention Deficit and Hyperactivity Disorder (ADHD), and use stimulant medication to participate in our study. We want to determine the role of ADHD stimulant medication on balance and other factors, such as physical activity in improving balance performance. We hypothesize that ADHD will improve balance performance in adults with ADHD. We also hypothesize that moderate to vigorous physical activity behaviors will positively influence balance performance in this population. Participants will be required to make two visits. Once on-medication; and on the second visit, we will ask participants to forgo ADHD medication 24 hours before the testing. For more information please contact Mansour at (205) 503-2977, or by email at amansour@uab.edu.
Published in
Clinical Trials
If you are 18 years of age or older, have tried at least 1 antidepressant medication, are feeling sad, down, hopeless, guilty, tense, or irritable, and are in good physical health, you may be eligible to participate in a research study comparing medications with transcranial magnetic stimulation. You will receive compensation for your time. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
The RECOVER study will investigate the use of Vagus Nerve Stimulation (VNS) Therapy in up to 1,000 people across the United States. To join the RECOVER study you must be 18 years or older and: currently depressed, have bi-polar depression that has lasted for at least two years or recurred several times, and have tried at least four types of antidepressant treatments and not found them helpful. Please leave a voice message at (205) 975-0068 or email candacegreen@uabmc.edu for more information.
Published in
Clinical Trials
You may be able to participate in this study if you: are 18 years of age or older, have been diagnosed with major depressive disorder, MDD, and have not adequately responded to at least 2 different antidepressant treatments. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
If you have Major Depressive Disorder (MDD) that hasn’t responded to anti-depressant medication, learn about this research study of an investigational drug for MDD. As part of their study participation, patients will be regularly evaluated and closely monitored by a team of medical professionals. To pre-qualify for this study, you must: be 18 to 65 years of age; have been diagnosed with MDD; be in a current depressive episode for at least 8 weeks but not more than 12 months; and have been taking an antidepressant medication for at least the last 8 weeks. Additional criteria will apply. All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
If you have major depressive disorder (MDD) and are in a current depressive episode, we invite you to learn about a research study of an investigational drug that is taken with your current antidepressant medication. In this study, researchers will evaluate the safety and efficacy of the investigational drug as an add-on therapy to your current antidepressant medication. To prequalify for this study you must be 18 to 65 years of age, have been diagnosed with recurrent MDD, be in a current major depressive episode for at least the last 8 weeks, and not experiencing a satisfactory improvement in your symptoms of depression with your current treatment. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
Major Depressive Disorder patients may be able to contribute to our understanding of depression. If you have Major Depressive Disorder (MDD) that hasn’t responded to anti-depressant medication, learn about this research study of an investigational drug for MDD. As part of their study participation, patients will be regularly evaluated and closely monitored by a team of medical professionals. To pre-qualify for this study, you must: be 18 to 65 years of age; have been diagnosed with MDD; be in a current depressive episode for at least 8 weeks but not more than 12 months; and have been taking an antidepressant medication for at least the last 8 weeks. Additional criteria will apply. All study-related visits, tests, and study drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
If you are 18 years of age or older. Have tried at least 1 antidepressant medication. Are feeling sad, down, or hopeless. Are feeling guilty, tense, or irritable, and are in good physical health. You may be eligible to participate in a research study comparing medications with transcranial magnetic stimulation. You will receive compensation for your time. Please leave a voice message at (205) 934-2484 or email lalexander@uabmc.edu for more information.
Published in
Clinical Trials
